(0.15%) 5 162.25 points
(0.14%) 38 888 points
(0.07%) 18 013 points
(0.79%) $78.73
(0.28%) $2.15
(0.62%) $2 322.90
(1.99%) $27.22
(0.08%) $966.05
(0.01%) $0.929
(-0.17%) $10.86
(-0.09%) $0.796
(0.35%) $91.77
@ $25.17
Utstedt: 14 feb 2024 @ 15:30
Avkastning: -14.58%
Forrige signal: feb 13 - 15:31
Forrige signal:
Avkastning: -0.59 %
Live Chart Being Loaded With Signals
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally...
Stats | |
---|---|
Dagens volum | 355 667 |
Gjennomsnittsvolum | 216 075 |
Markedsverdi | 640.37M |
EPS | $0 ( 2024-05-03 ) |
Neste inntjeningsdato | ( $-0.320 ) 2024-05-16 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.87 |
ATR14 | $0.0290 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Hsieh Ming | Sell | 1 337 | Common Stock |
2024-04-30 | Gao Hanlin | Sell | 79 | Common Stock |
2024-04-26 | Xie Jian | Sell | 4 344 | Common Stock |
2024-04-26 | Kim Paul | Sell | 2 738 | Common Stock |
2024-04-26 | Gao Hanlin | Sell | 1 154 | Common Stock |
INSIDER POWER |
---|
1.33 |
Last 99 transactions |
Buy: 2 001 398 | Sell: 1 963 075 |
Volum Korrelasjon
Fulgent Genetics Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
SSTI | 0.962 |
FWRD | 0.958 |
PACB | 0.958 |
CCSI | 0.958 |
RIVN | 0.956 |
WW | 0.954 |
NVTS | 0.953 |
ESCA | 0.952 |
APPS | 0.951 |
GP | 0.951 |
10 Mest negative korrelasjoner | |
---|---|
GXII | -0.966 |
DXJS | -0.963 |
MSAC | -0.961 |
AGGR | -0.959 |
HERA | -0.957 |
AEAC | -0.956 |
TBSAU | -0.956 |
CRZN | -0.955 |
ABGI | -0.955 |
HERAU | -0.955 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Fulgent Genetics Inc Korrelasjon - Valuta/Råvare
Fulgent Genetics Inc Økonomi
Annual | 2023 |
Omsetning: | $289.21M |
Bruttogevinst: | $96.61M (33.40 %) |
EPS: | $-5.63 |
FY | 2023 |
Omsetning: | $289.21M |
Bruttogevinst: | $96.61M (33.40 %) |
EPS: | $-5.63 |
FY | 2022 |
Omsetning: | $618.97M |
Bruttogevinst: | $366.90M (59.28 %) |
EPS: | $4.76 |
FY | 2021 |
Omsetning: | $992.58M |
Bruttogevinst: | $777.05M (78.29 %) |
EPS: | $17.25 |
Financial Reports:
No articles found.
Fulgent Genetics Inc
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related variants and repeat expansions through sequencing; picture genetics, a patient-initiated genetic testing; whole exome and clinical exome panel tests; whole genome, mutation, and repeat expansion testing services, as well as research service tests. It also provides next generation sequencing and reverse transcription polymerase chain reaction-based tests, as well as antigen-based diagnostic tests for the detection of SARS-CoV-2. In addition, the company offers flow cytometry, a cell analysis technique providing diagnosis, prognosis, and monitoring of malignancies; fluorescence in-situ hybridization for detecting and locating a specific DNA sequence on a chromosome; immunohistochemistry, an imaging technique used to visualize antigens in cells; cytogenetics, which analyzes the chromosome set for numerical and structural abnormalities; and molecular testing that includes hematopoietic and solid tumor molecular assays. The company serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. Fulgent Genetics has strategic partnership with Helio Health, Inc. to commercialize blood-based early cancer detection tests. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.